立妙达

Biotech/Healthcare

Limiaoda is an AI-powered small-molecule drug developer focused on using AI to discover and translate small-molecule lead compounds. The company is building a new drug development pipeline spanning artificial intelligence, computational chemistry, and medicinal chemistry.

Latest round: Series A (2024)